Literature DB >> 9015384

Purification and characterization of hepatic aldehyde oxidase in male and female mice.

S Yoshihara1, K Tatsumi.   

Abstract

To examine whether the hepatic aldehyde oxidases of male and female mice, which exhibit sex-related differences in benzaldehyde oxidation, are qualitatively different, we purified the enzymes from untreated male and female ddy mice and testosterone-pretreated female mice by sequential chromatography of benzamidine-Sepharose 6B and DEAE-5PW columns and characterized the enzymes. Purified enzymes from untreated male and female mice and from testosterone-treated females gave a single protein band at M(r) 265K and M(r) 138K on native and SDS-polyacrylamide gradient gel electrophoresis, respectively. The susceptibilities of the enzymes from both sexes to inhibitors such as menadione, norharman, quinacrine, estradiol, and SKF 525-A were also indistinguishable. However, the K(m) values for benzaldehyde, p-dimethylaminocinnamaldehyde, and 2-hydroxypyrimidine were two- to fourfold higher in the untreated female enzyme than in the untreated male enzyme, while the testosterone-induced female enzyme showed K(m) values similar to those of the male enzyme. These results indicate that the hepatic aldehyde oxidases of the sexes are quite similar with respect to molecular size and susceptibility to inhibitors, but their kinetic properties are somewhat different, suggesting the existence of microheterogeneity in sex differences. It also suggests that treatment of female mice with testosterone might induce the male-type enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015384     DOI: 10.1006/abbi.1996.9774

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.

Authors:  L S Ireland; D J Harrison; G E Neal; J D Hayes
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

2.  Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.

Authors:  Christine B Yoo; Jody C Chuang; Hyang-Min Byun; Gerda Egger; Allen S Yang; Louis Dubeau; Tiffany Long; Peter W Laird; Victor E Marquez; Peter A Jones
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-19

3.  Identification and characterization of an antennae-specific aldehyde oxidase from the navel orangeworm.

Authors:  Young-Moo Choo; Julien Pelletier; Elizabeth Atungulu; Walter S Leal
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

4.  Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin.

Authors:  M Terao; M Kurosaki; S Demontis; S Zanotta; E Garattini
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.